DIZAC (diazepam) by Pfizer is mechanism of action although the precise mechanism by which diazepam exerts its antiseizure effects is unknown, animal and in vitro studies suggest that diazepam acts to suppress seizures through an interaction with γ-aminobutyric acid (gaba) receptors of the a-type (gaba a ).
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
DIZAC (diazepam) is an injectable benzodiazepine that acts as a CNS depressant by enhancing GABA receptor activity to suppress seizure activity. It is indicated for acute seizure management and anxiety disorders via the parenteral route. The drug works by facilitating chloride ion influx into neurons, reducing excessive depolarization and seizure propagation.
Pre-launch stage suggests newly formed commercial teams ramping for market entry; career opportunities concentrated in launch planning, regulatory affairs, and early field build.
Mechanism of Action Although the precise mechanism by which diazepam exerts its antiseizure effects is unknown, animal and in vitro studies suggest that diazepam acts to suppress seizures through an interaction with γ-aminobutyric acid (GABA) receptors of the A-type (GABA A ). GABA, the major…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants
Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy
Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán
Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy
A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers
Worked on DIZAC at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on DIZAC offers entry into acute care and hospital-based commercial roles within Pfizer's established infrastructure. The pre-launch stage provides visibility into market strategy and launch execution, though limited by absence of clinical expansion opportunities and short patent runway.